Showing 10 out of 25 companies.
Johnson & Johnson, Eli Lilly and Co, AbbVie Inc, Merck & Co Inc, and Pfizer Inc are the top 5 pharma companies in the US in 2023 by market capitalization (as of Mar 31, 2023). Comprehensively, the top 10 Pharma companies in the US had a total market cap of $2,060,644 million (as of Mar 31, 2023), with Johnson & Johnson having the highest ($402,750 million), followed by Eli Lilly and Co ($327,055 million), and AbbVie Inc ($281,151 million), while Vertex Pharmaceuticals Inc is the lowest ($81,002 million). Johnson & Johnson is the leading Pharma company by market cap in the US (as of Mar 31, 2023). The company reported revenues of $94,943 million for the fiscal year ended January 2022 (FY2022), an increase of 1.2% over FY2021. The Company research, develops, manufactures, and sells pharmaceutical products, medical devices, and consumer products. The company conducts its business through more than 260 subsidiaries and 85 manufacturing facilities in over 60 countries globally and employs 152,700 people. Eli Lilly and Co is another leading Pharma company in the US by market cap (as of Mar 31, 2023). The company reported revenues of $28,541 million for the fiscal year ended December 2022 (FY2022), an increase of 0.8% over FY2021. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, cancer, neurological problems, immune disorders, men's health, and musculoskeletal problems. It employs 39,000 people.
